News for Qorvo Inc (2QO.BE)

Our indicative theme of 5G Stocks – which includes U.S.-based companies that stand to benefit from the ongoing transition of the wireless industry to 5G - is down by about -1.6% year-to-date, compared to the S&P 500 which is up by about 2% over the same period. However, the theme has outperformed...

One of the best resources for investors are the publicly available 13F-HR documents that each fund is required to submit to the SEC. These documents allow inves...

Whenever there is a changeover in the White House, particularly when there is a change in party, certain stocks tend to move more than others. In some cases, these moves might be related to the...

Our indicative theme on Apple Component Supplier Stocks – which includes a diverse set of companies that supply components for iPhones and other Apple devices - is up by about 37% since the end of 2019, compared to a gain of about 22% on the S&P 500. The theme has also returned about 7.5%...

Seth Klarman Buys Into Intel and Marathon Petroleum in 4th Quarter, Stocks: INTC,MPC,HDS,HPQ,VIAC,EBAY,LBTYK,QRVO,FOXA, Seth Klarman, release date:Feb 16, 2021

Seth Klarman Buys Into Intel and Marathon Petroleum in 4th Quarter, Stocks: INTC,MPC,HDS,HPQ,VIAC,EBAY,LBTYK,QRVO,FOXA, Seth Klarman, release date:Feb 16, 2021

For investors searching for the best 5G stocks, Qorvo Inc (NASDAQ:QRVO) deserves a serious look. Here's why QRVO stock is worth investigating.

Seth Klarman Focuses on Core Holdings in Baupost's Latest Quarter, Stocks: INTC,MPC,QRVO,FOXA,PSTH,VIAC,EBAY, Seth Klarman, release date:Feb 15, 2021

Seth Klarman Focuses on Core Holdings in Baupost's Latest Quarter, Stocks: INTC,MPC,QRVO,FOXA,PSTH,VIAC,EBAY, Seth Klarman, release date:Feb 15, 2021

Pune, India, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The global microwave devices market size is expected to gain momentum by reaching USD 9.00 billion by 2027 ...

Covina CA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The global 5G semiconductor solutions market accounted for US$ 1.5 billion in 2020 and is estimated to be US$ ...

Pune, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Market AnalysisMarket Research Future (MRFR) expects the global compound semiconductor market Size to touch USD ...

SAN DIEGO, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that presentation recordings from its 5-day Next-Generation Cytogenomics Symposium, which took place from January 11 to 15 and featured 33 presentations by Saphyr users, are now available online on the company’s website and its YouTube page. This event was by far its highest attended to date, with more than 15,500 session registrations and more than 6,400 session views from around the world. With the presentation recordings now available online, the impact of the event can continue to grow and expand awareness of Bionano Genomics and its Saphyr system for optical genome mapping and structural variation analysis. The event brought together scientists from leading hospitals and medical research institutions from the United States, Europe, China and Australia and covered applications of optical genome mapping (OGM) with Saphyr to study a variety of genetic diseases, blood cancers, solid tumors and repeat disorders as well as the studies supporting validation of clinical assays developed by Saphyr users. The last day of the symposium was dedicated to the study of the genomes of severely ill COVID-19 patients. Erik Holmlin, PhD, CEO of Bionano Genomics, commented: “The symposium was our most prominent showcase to date of how Saphyr comprehensively detects structural variations in a wide range of clinical and research applications. We are pleased by the enthusiasm we have seen from the scientific community around the world, and the impact of the symposium on our effort to sell Saphyr systems and access to its data through our services and reagent rental programs has been immediate. The availability of this scientific content on YouTube makes its discovery easy and continue to educate our customers on the power of Saphyr data.” The recorded presentations of all speakers can be viewed on bionanogenomics.com at https://bionanogenomics.com/library/videos/ and on Bionano’s YouTube page at https://www.youtube.com/c/bionanogenomics. About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit www.bionanogenomics.com or www.lineagen.com. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the anticipated benefits of the symposium and continued access to the symposium, including on Bionano’s sales efforts; and the execution of Bionano’s strategy. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of the COVID-19 pandemic on our business and the global economy; general market conditions; changes in the competitive landscape and the introduction of competitive products; changes in our strategic and commercial plans; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; the ability of medical and research institutions to obtain funding to support adoption or continued use of our technologies; the loss of key members of management and our commercial team; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2019 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. CONTACTSCompany Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858) [email protected] Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLC+1 (617) [email protected] Media Contact:Darren Opland, PhDLifeSci Communications+1 (617) [email protected]

SEATTLE, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in a fireside chat during the Guggenheim Healthcare Talks | 2021 Oncology Days on Friday, March 12, 2021 at 3 p.m. Eastern Time. A live audio webcast of the corporate presentation and question and answer session to follow will be available from the investors section of the Neoleukin website at http://investor.neoleukin.com/events. An archived replay will also be available on the company website for at least 30 days following the event. About Neoleukin Therapeutics, Inc. Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Neoleukin’s lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface. For more information, please visit the Neoleukin website: www.neoleukin.com. Safe Harbor / Forward-Looking Statements This press release contains "forward-looking" statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, planned development activities and timelines, and the therapeutic properties and potential benefits of the company’s product candidates and de novo protein design technology. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. These statements are subject to numerous risks and uncertainties, including risks and uncertainties related to the company’s cash forecasts, the company’s ability to advance its product candidates, the receipt and timing of potential regulatory submissions, designations, approvals and commercialization of product candidates, the timing and results of preclinical and clinical trials, the timing of announcements and updates relating to the company’s clinical trials and related data market conditions and further impacts of COVID-19, that could cause actual results to differ materially from what Neoleukin expects. Further information on potential risk factors that could affect Neoleukin’s business and its financial results are detailed under the heading “Risk Factors” in documents the company files from time to time with the Securities and Exchange Commission (SEC), and other reports as filed with the SEC. Neoleukin undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Contacts: MediaJulie [email protected] InvestorsSolebury TroutBrian [email protected]

XTM, Inc. ("XTM" or the "Company") (OTCQB: XTMIF) (CSE: PAID), (FSE: 7XT), a Miami and Toronto-based Fintech company in the neo-banking space, providing mobile banking and payment solutions around the world, is pleased to announce it will launch its payment solution as a continuation of the Black Fox restaurant management tracking app.

Company announcement no. 3/2021 Notice convening NNIT Annual General Meeting The Annual General Meeting of NNIT A/S will be held on: Wednesday March 10, 2021 at 2.00 pm to 4.00 pm (CET) as an electronic event without any possibility of attendance in person. The notice for the Annual General Meeting, including Appendix A: Candidates for (re-) election to the Board of Directors and Appendix B: Remuneration Policy is attached. Board of Directors - Election of members to the Board of Directors, including Chairman and Deputy Chairman The Board of Directors proposes to re-elect Anne Broeng, Carsten Dilling, Peter Haahr, Christian Kanstrup, Eivind Kolding and Caroline Serfass to the Board of Directors. Further, it is proposed that Carsten Dilling is re-elected as Chairman of the Board of Directors and that Peter Haahr is re-elected as Deputy Chairman of the Board of Directors. Contact for further informationInvestor relations: Jens BingerHead of Investor Relations & TreasuryTel: +45 3079 [email protected] Press:Tina Joanne HindsboMedia Relations Manager Tel: +45 3077 [email protected] The NNIT Group provides a wide range of IT and consulting services to the world. Supporting the entire supply chain, we help optimize internal company processes, production and sales as well as delivery to customers. We are experts in supporting the world’s most regulated industries subject to strict governance of processes, quality and data management and documentation – and in guiding them on their digital journey. The Group consists of group company NNIT A/S and the subsidiaries Valiance, SCALES and Excellis Health Solutions. Together, these companies employ over 3,000 people, primarily in Europe, Asia and the USA. In Denmark, where the Group HQ is based, we are one of the leading IT consultancies, servicing both private and public sector customers across all industries. In the rest of Europe, USA and Asia, we are solely focused on companies within life sciences. Read more at www.nnit.com Attachment 03 02052021 Notice convening the annual general meeting for NNIT v1

Global IoT Device Management Market By Component (Software v/s Service), By Deployment Mode (On-Premise v/s Cloud), By Organization Size (Large Enterprises v/s SMEs), By Application (Smart Retail, Connected Health, Connected Logistics, Smart Utilities, Smart Manufacturing, Others), By Company, By Region, Forecast & Opportunities, 2026New York, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global IoT Device Management Market By Component, By Deployment Mode, By Organization Size, By Application, By Company, By Region, Forecast & Opportunities, 2026" - https://www.reportlinker.com/p06020708/?utm_source=GNW The Global IoT Device Management Market is expected to grow at a robust rate of around 22% during the forecast period.The Global IoT Device Management Market is driven by the increasing incidences of cybercrimes and cyber threats which has led to the increase in security concerns within enterprises.This in turn increases the need to deploy IoT solutions for ensuring organizational safety and security thereby driving the growth of the Global IoT Device Management Market during forecast period.Additionally, the increasing penetration of communication and networking technologies further fosters the market growth.Furthermore, the extensive adoption of sensors is expected to create lucrative opportunities for the market growth through 2026.However, lack of IT infrastructure and finances in the emerging countries can hamper the market growth over the next few years.Moreover, lack of standardization also impedes the market growth.The Global IoT Device Management Market is segmented based on component, deployment mode, organization size, application, company and region.Based on component, the market can be bifurcated into solution and service.The solution segment can further be categorized into real-time streaming analytics, security solution, data management, remote monitoring and network bandwidth management.The data management segment is expected to register significant growth in the market owing to the increasing penetration of networking & communication technologies coupled with increasing incidences of data breaches and cybercrime.The service segment helps the organizations in easily deploying the software on cloud.It can further be divided into professional and managed services.Based on deployment mode, the market can be split into on-premise and cloud. The cloud segment is expected to dominate the market on account of its associated advantages such as scalability, flexibility, 24/7 availability, reduced operational costs, auto update feature, among others. Based on end-user, the market can be fragmented into smart retail, connected health, connected logistics, smart utilities, smart manufacturing and others. The smart manufacturing segment is expected to dominate the market on account of the widespread use of IoT device management solutions in production, procurement and storage of goods manufactured.Regionally, the Global IoT Device Management Market has been segmented into various regions including Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected dominate the overall IoT device management market owing to the increasing investments by the major players operating in the market coupled with the government support for development of IoT solutions in the region.The major players operating in the Global IoT Device Management Market are Microsoft Corporation, PTC Incorporation, Telit Communications PLC, IBM Corporation, Oracle Corporation, Smith Micro Software, Inc., Advantech Co. Ltd., Aeris Communications, LLC, Zentri, Cumulocity GmbH, Enhanced Telecommunications Inc., Amplia Soluciones S.L., Proximetry, Bosch Software Innovation GmbH, Wind River, SiteWhere LLC, Xively, VMware Inc., Matrix42 AG, Amazon Web Services, Inc. and others. Major companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.Years considered for this report:Historical Years: 2016-2019Base Year: 2020Estimated Year: 2021Forecast Period: 2022–2026Objective of the Study:• To analyze and estimate the market size of the Global IoT Device Management Market from 2016 to 2019.• To estimate and forecast the market size of the Global IoT Device Management Market from 2020 to 2026 and growth rate until 2026.• To classify and forecast the Global IoT Device Management Market based on component, deployment mode, organization size, end-user, company and regional distribution.• To identify dominant region or segment in the Global IoT Device Management Market.• To identify drivers and challenges for the Global IoT Device Management Market.• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global IoT Device Management Market.• To identify and analyze the profile of leading players operating in the Global IoT Device Management Market.• To identify key sustainable strategies adopted by market players in the Global IoT Device Management Market.The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of service providers across the globe.Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.Through this technique, the analyst could include the service providers which could not be identified due to the limitations of secondary research. The analyst examined the service providers, distribution channels and presence of all major players across the globe.The analyst calculated the market size of the Global IoT Device Management Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.Key Target Audience:• IoT device management service provider companies• Market research and consulting firms• Government bodies such as regulating authorities and policy makers• Organizations, forums and alliances related to IoT device managementThe study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.Report Scope:In this report, the Global IoT Device Management Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:• Global IoT Device Management Market, By Component:o Solution Real-Time Streaming Analytics Security Solution Data Management Remote Monitoring Network Bandwidth Managemento Service Professional Managed• Global IoT Device Management Market, By Deployment Mode:o On-Premiseo Cloud• Global IoT Device Management Market, By Organization Size:o Large Enterpriseso SMEs• Global IoT Device Management Market, By End-User:o Smart Retailo Connected Healtho Connected Logisticso Smart Utilitieso Smart Manufacturingo Others• Global IoT Device Management Market, By Region:o North America United States Canada Mexicoo Europe Germany France United Kingdom Italy Spaino Asia-Pacific China Japan India South Korea Australiao Middle East & Africa South Africa Saudi Arabia UAE Kuwaito South America Brazil Argentina ColombiaCompetitive LandscapeCompany Profiles: Detailed analysis of the major companies present in the Global IoT Device Management Market.Available Customizations:With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information• Detailed analysis and profiling of additional market players (up to five).Read the full report: https://www.reportlinker.com/p06020708/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Identity of the person whose positions/dealings are being disclosed:Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Asset Management LP acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree RSA Insurance Group Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:04th February 2021(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: GBP 100p ordinaryISIN: GB00BKKMKR23 InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled:250,5300.0242% (2) Derivatives CFD (other than options): 19,196,1011.8541% (3) Options and agreements to purchase/sell: TOTAL:19,446,6311.8783% All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other executive options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant securityPurchase/sale Number of securitiesPrice per unit (b) Derivatives transactions (other than options) Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitGBPGBP 100p ordinary CFDDecrease a long position2,070678.20 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc. Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercising Class of relevant securityProduct descriptione.g. call optionNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached ?NO Date of disclosure:05th February 2021Contact name: Deborah GewinnerTelephone number: +44 203 751 54 12 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk. Attachment 04.02.2021 RSA Insurance Group Plc

MONTREAL, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX:SJ). OPEN TO: Investors, analysts, and all interested parties DATE:Wednesday, March 10, 2021 TIME: 10:00 a.m. EDT CALL:647-788-4922 (For all Toronto and overseas participants) 1-877-223-4471 (For all other North American participants) THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL THROUGH GLOBENEWSWIRE. Please dial in 15 minutes before the conference begins. If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-585-8367 and entering the passcode 8518287 on your phone. This recording will be available on Wednesday, March 10, 2021 as of 1:00 p.m. until 11:59 p.m. on Wednesday, March 17, 2021. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION. For further information, please contact Pierre Boucher of MaisonBrison at 514-731-0000.